(Q38932122)

7 September 2017

0 references

Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific (English)

1 reference

7 September 2017

1 reference

hepatitis E virus

1 reference

based on heuristic

inferred from title

author

Maikel P Peppelenbosch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25476751%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Qiuwei Pan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25476751%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Lei Xu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25476751%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Xinying Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25476751%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

5 December 2014

1 reference

25476751

7 September 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Archives of Virology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25476751%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25476751%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25476751%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

435-439

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25476751%20AND%20SRC:MED&resulttype=core&format=json

The Ubiquitin-Proteasome System Regulates the Accumulation ofTurnip yellow mosaic virusRNA-Dependent RNA Polymerase during Viral Infection

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

The ubiquitin-proteasome system in positive-strand RNA virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Sindbis virus RNA polymerase is degraded by the N-end rule pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Signals in hepatitis A virus P3 region proteins recognized by the ubiquitin-mediated proteolytic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

The ubiquitin-proteasome pathway in viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Ubiquitin-independent degradation of hepatitis C virus F protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

SARS-CoV nucleocapsid protein binds to hUbc9, a ubiquitin conjugating enzyme of the sumoylation system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Epidemiology and management of chronic hepatitis E infection in solid organ transplantation: a comprehensive literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Hepatitis E virus replication requires an active ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Rapamycin and everolimus facilitate hepatitis E virus replication: revealing a basal defense mechanism of PI3K-PKB-mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Translational control by viral proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Evaluation of the susceptibility of the 3C proteases of hepatitis A virus and poliovirus to degradation by the ubiquitin-mediated proteolytic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Identification and characterization of a protein destruction signal in the encephalomyocarditis virus 3C protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

The ubiquitin-proteasome system is required for the early stages of porcine circovirus type 2 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

The proteasome: a suitable antineoplastic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

Proteasome inhibition: a new anti-inflammatory strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2303-0

10.1007/S00705-014-2303-0

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25476751%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25476751%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

25476751

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25476751%20AND%20SRC:MED&resulttype=core&format=json